Determination of radiosensitivity in established and primary squamous cell carcinoma cultures using the micronucleus assay

European Journal of Cancer Part A

Volumn 33, Issue 3, 1997, Pages 453-462

  Champion, A R ^a   Hanson, J A ^a   Venables, S E ^a   McGregor, A D ^b   Gaffney, C C ^a  

^a VELINDRE CANCER CENTRE   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

Author keywords

DNA damage; micronucleus assay; predictive assay; squamous cell carcinoma; tumour cell radiosensitivity

Indexed keywords

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MICRONUCLEUS TEST; PRIORITY JOURNAL; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

EID: 0031105621     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)89022-3     Document Type: Article

References (38)

1. Streffer C, van Beuningen D, Gross E, Schabronath J, Eigler F-W, Rebmann A. Predictive assays for the therapy of rectum carcinoma. Radiother Oncol. 5:1986;303-310.
2. Peters LJ. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother Oncol. 17:1990;177-190.
3. Fertil B, Malaise EP. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys. 7:1981;621-629.
4. West CML, Davidson SE, Roberts SA, Hunter RD. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer. 68:1993;819-823.
5. Brock WA, Baker FL, Wike JL, Sivon SL, Peters LJ. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys. 18:1990;1283-1286.
6. Girinsky T, Bernheim A, Lubin R, et al. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival. Int J Radiat Oncol Biol Phys. 30:1994;789-794.
7. Rockwell S. Effects of clumps and clusters on survival measurements with clonogenic assays. Cancer Res. 45:1985;1601-1607.
8. Baker FL, Spitzer G, Ajani JA, et al. Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium. Cancer Res. 46:1986;1263-1274.
9. Streffer C, Van Beuningen D, Molls M. Possibilities of the micronucleus test as an assay in radiotherapy. Karcher KK. Progress in Radio-Oncology II. 1982;243-251 Raven Press, New York.
10. Shibamoto Y, Streffer C, Fuhrmann C, Budach V. Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay. Radiat Res. 128:1991;293-300.
11. Fenech M, Morley AA. Solutions to the kinetic problem in the micronucleus assay. Cytobios. 43:1985;233-246.
12. Carter SB. Effects of cytochalasins on mammalian cells. Nature. 213:1967;261-264.
13. Fuhrmann C, Streffer C, Muller W-C, Becker U. Micronucleus assay prediction and application optimized by cytochalasin B-induced binucleated tumor cells. Strahlenther Onkol. 168:1992;603-609.
14. Champion AR, Hanson JA, Court JB, Venables SE. The micronucleus assay: an evaluation of its use in determining radiosensitivity in vitro. Mutagenesis. 10:1995;203-208.
15. Midander J, Revesz L. The frequency of micronuclei as a measure of cell survival in irradiated cell populations. Int J Radiat Biol. 38:1980;237-242.
16. Stap J, Aten JA. Comparison of radiation sensitivity for three cell lines as measured by the cloning assay and the micronucleus test. Strahlenther Onkol. 166:1990;761-763.
17. Bakker PJM, Tukker LJ, Stap J, Veenhok CHN, Aten JA. Micronuclei expression in tumours as a test for radiation sensitivity. Radiother Oncol. 26:1993;69-72.
18. Bush C, McMillan TJ. Micronucleus formation in human tumour cells: lack of correlation with radiosensitivity. Br J Cancer. 67:1993;102-106.
19. Slavotinek A, McMillan TJ, Steel CM. A comparison of micronucleus frequency and radiation survival in lymphoblastoid cell lines. Mutagenesis. 8:1993;569-575.
20. Peters LJ, Brock WA, Johnson T, Meyn RE, Tofilon PJ, Milas L. Potential methods for predicting tumor radiocurability. Int J Radiat Oncol Biol Phys. 12:1986;4590-5467.
21. Wandl EO, Ono K, Kain R, Herbsthofer T, Hienert G, Hobarth K. Linear correlation between surviving fraction and the micronucleus frequency. Int J Radiat Biol. 56:1989;771-775.
22. Shibamoto Y, Shibata T, Miyatake S, et al. Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay. Br J Cancer. 70:1994;67-71.
23. Zolzer F, Alberti W, Pelzer T, Lamberti G, Hulskamp FH, Streffer C. Changes in S-phase fraction and micronucleus frequency as prognostic factors in radiotherapy of cervical carcinoma. Radiother Oncol. 36:1995;128-132.
24. Villa R, Zaffaroni N, Gornati D, Costa A, Silvestrini R. Lack of correlation between micronucleus formation and radiosensitivity in established and primary cultures of human tumours. Br J Cancer. 70:1994;1112-1117.
25. Weichselbaum RR, Dahlberg W, Little JB, et al. Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy. Br J Cancer. 49:1984;595-601.
26. Weichselbaum RR, Beckett MA, Schwartz JL, Dritschilo A. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys. 15:1988;575-579.
27. Cobleigh MA, Kennedy JL, Wong AC, et al. Primary culture of squamous head and neck cancer with and without 3T3 fibroblasts and effect of clinical tumor characteristics on growth in vitro. Cancer. 59:1987;1732-1738.
28. Parkinson EK, Yeudall WA. Epidermis. Masters JRW. Human Cancer in Primary Culture: A Handbook. 1991;187-197 Kluwer Academic Publishers, London. Chapter 8.
29. House W. Bulk culture of cell monolayers. Kruse PF, Patterson MK. Tissue Culture: Methods and Applications. 1973;338-344 Academic Press, New York and London.
30. Nash JC. Compact Numerical Methods for Computer. Linear Algebra and Function Minimisation. 1979;Adam Hilger, Bristol.
31. Grenman R, Carey TE, McClatchey KD, et al. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer. 67:1991;2741-2747.
32. Pekkola-Heino K, Joensuu H, Klemi P, Grenman R. Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous carcinoma cell lines. Arch Otolaryngol Head Neck Surg. 120:1994;750-754.
33. Brock WA, Baker FL, Peters LJ. Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability. Int J Radiat Biol. 56:1989;751-760.
34. Girinsky T, Lubin R, Pignon JP, et al. Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys. 25:1992;3-7.
35. Begg AC, Hofland I, Van Glabekke M, Bartelink H, Horiot JC. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: results from the EORTC cooperative trial 22851. Semin Radiat Oncol. 2:1992;22-25.
36. Corvo R, Giaretti W, Sanguineti G, et al. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. Int J Radiat Oncol Biol Phys. 27:1993;1165-1172.
37. Tytor M, Franzen G, Olofsson J. DNA ploidy in oral cavity carcinomas, with special reference to prognosis. Head Neck. 11:1989;257-263.
38. Guo YC, DeSanto L, Osetinsky GV. Prognostic implications of nuclear DNA content in head and neck cancer. Otolaryngol Head Neck Surg. 100:1989;95-98.